These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18175946)

  • 1. Comparative examination of anti-proliferative activities of (-)-epigallocatechin gallate and (--)-epigallocatechin against HCT116 colorectal carcinoma cells.
    Inaba H; Nagaoka Y; Kushima Y; Kumagai A; Matsumoto Y; Sakaguchi M; Baba K; Uesato S
    Biol Pharm Bull; 2008 Jan; 31(1):79-84. PubMed ID: 18175946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
    Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.
    Ding YP; Gao ZL; Chen BC; Rakariyatham K; Suo HY; Tong HR; Xiao H
    Nutr Cancer; 2018 Oct; 70(7):1126-1136. PubMed ID: 30513211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK.
    Lu LH; Lee SS; Huang HC
    Br J Pharmacol; 1998 Jul; 124(6):1227-37. PubMed ID: 9720795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
    Gao Y; Li W; Jia L; Li B; Chen YC; Tu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):370-4. PubMed ID: 23892041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.
    Kürbitz C; Heise D; Redmer T; Goumas F; Arlt A; Lemke J; Rimbach G; Kalthoff H; Trauzold A
    Cancer Sci; 2011 Apr; 102(4):728-34. PubMed ID: 21241417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
    Shih LJ; Lin YR; Lin CK; Liu HS; Kao YH
    Placenta; 2016 May; 41():1-9. PubMed ID: 27208402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer.
    Maruyama T; Murata S; Nakayama K; Sano N; Ogawa K; Nowatari T; Tamura T; Nozaki R; Fukunaga K; Ohkohchi N
    Oncol Rep; 2014 Feb; 31(2):625-33. PubMed ID: 24337301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
    Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
    J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells.
    Han DH; Kim JH
    Arch Pharm Res; 2009 Apr; 32(4):543-7. PubMed ID: 19407972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
    Manohar M; Fatima I; Saxena R; Chandra V; Sankhwar PL; Dwivedi A
    J Nutr Biochem; 2013 Jun; 24(6):940-7. PubMed ID: 22959059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways.
    Zhang T; Yang D; Fan Y; Xie P; Li H
    Apoptosis; 2009 Oct; 14(10):1245-54. PubMed ID: 19669889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells.
    Cordero-Herrera I; Martín MA; Bravo L; Goya L; Ramos S
    Nutr Cancer; 2013; 65(5):718-28. PubMed ID: 23859040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
    Lim YC; Cha YY
    J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.